ImmunityBio Inc. (IBRX)
2.38
0.06 (2.59%)
At close: Jan 15, 2025, 11:40 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -4.38 | -4.86 | -6.76 | -22.78 | -9.07 | -0.95 | -3.75 | -3.88 | -5.23 | -1.76K | -13.49 |
| PS Ratio | 4.11K | 8.45K | 2.53K | 8.44K | 659.51 | 1.95K | 8.04K | 10.66K | 5.25K | 17.06K | 46.02 |
| PB Ratio | -4.35 | -4.53 | -9.77 | -42.63 | 12.03 | 0.63 | 1.65 | 1.60 | 3.48 | 187.20 | -9.54 |
| P/FCF Ratio | -6.43 | -4.64 | -7.68 | -29.46 | -9.29 | -1.2 | -4.33 | -10.39 | -45 | -1.93K | -41.15 |
| P/OCF Ratio | -6.96 | -6.01 | -8.62 | -29.74 | -9.55 | -1.45 | -7.42 | -12.15 | -48.98 | -2.04K | -41.33 |
| OCF/S Ratio | -589.64 | -1.41K | -293.81 | -283.84 | -69.08 | -1.35K | -1.08K | -877.11 | -107.22 | -8.35 | -1.11 |
| Debt / Equity Ratio | -1.24 | -1.62 | -2.67 | -2.3 | 0.12 | 0.05 | 0.03 | 0.03 | 0.01 | 0.00 | -0.61 |
| Quick Ratio | 5.05 | 0.23 | 0.91 | 1.64 | 4.82 | 3.26 | 6.35 | 16.34 | 48.40 | 24.69 | 0.20 |
| Current Ratio | 5.05 | 0.28 | 0.91 | 1.64 | 4.82 | 3.26 | 6.35 | 16.34 | 48.40 | 24.69 | 0.20 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.29 |
| Interest Coverage | -2.8 | -5.53 | -22.24 | -24.34 | -26.39 | -227.23 | -160.39 | -1.89K | n/a | n/a | -4.9 |
| Return on Equity (ROE) | 0.99 | 0.93 | 1.44 | 1.87 | -1.33 | -0.66 | -0.44 | -0.41 | -0.67 | -0.11 | 0.71 |
| Return on Assets (ROA) | -1.16 | -1.15 | -0.75 | -1.01 | -1.12 | -0.53 | -0.39 | -0.38 | -0.65 | -0.1 | -0.97 |
| Return on Capital (ROIC) | -0.81 | 2.54 | -3.31 | -1.44 | -1.19 | -0.64 | -0.43 | -0.41 | -0.66 | -0.11 | 0.78 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | -9.98K% | 100.00% | -1.41K% | -309.26% | 6.72K% | 100.00% | 100.00% | 100.00% | 100.00% | 57.83% |
| Net Profit Margin | -93.76K% | -173.88K% | -37.46K% | -37.06K% | -7.27K% | -204.74K% | -214.27K% | -274.57K% | -100.37K% | -969.27% | -341.17% |
| Pretax Profit Margin | -93.87K% | -173.87K% | -37.46K% | -37.36K% | -7.28K% | -205.81K% | -215.37K% | -275.87K% | -100.50K% | -969.11% | -341% |
| Operating Profit Margin | -58.24K% | -146.37K% | -35.36K% | -36.51K% | -7.10K% | -209.34K% | -220.27K% | -282.95K% | -101.22K% | -969.11% | -378.17% |
| FCF Margin | -63.88K% | -182.04K% | -32.97K% | -28.66K% | -7.10K% | -162.73K% | -185.77K% | -102.62K% | -11.67K% | -881.9% | -111.83% |
| EBITDA Margin | -70.13K% | -139.80K% | -33.77K% | -31.06K% | -6.46K% | -184.56K% | -201.63K% | -267.52K% | -99.88K% | -885.65% | -263.17% |